Short answer
Tectonic Therapeutic, Inc. (TECX) filed an 8-K current report with the SEC on February 24, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Terrance McGuire resigning as Board Chair effective April 1, 2026; full Board exit at 2026 annual meeting.
Tectonic Therapeutic, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Terrance McGuire resigning as Board Chair effective April 1, 2026; full Board exit at 2026 annual meeting
- François Nader appointed Board Chair (effective April 1, 2026) and Class III director through 2027 annual meeting
- Nader compensation: $40K annual cash retainer + $30K Chair premium + 20,400 stock option initial grant
- Initial options vest 1/3 at year one, remainder monthly through year three; full acceleration on change of control
- Leadership transition signals potential strategic shift; incoming Chair's independence (Nasdaq-qualified) preserves governance standards
Item 7.01 · Regulation FD Disclosure
- Reg FD disclosure via Exhibits 99.1 and 99.2: content of those exhibits is the material information for investors to review
- Filing structured as "furnished" not "filed": limits legal liability under Exchange Act Section 18, standard for investor presentations/press releases
- Exhibits not automatically incorporated by reference into future SEC filings unless explicitly cited
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tectonic Therapeutic, Inc. 8-K filings
Get the next TECX 8-K as it lands
Follow TECX for push alerts, or ask the research agent what this filing means.